Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
lyophilisat pour usage parentéral
DRUG
2 trials
Sponsors
CHRU De Nancy
, Institut Curie
Conditions
Cardiogenic Shock
Retinoblastoma
Phase 2
RB SFCE 2009 : Adjuvant treatment in extensive unilateral retinoblastoma primary enucleated
Active, not recruiting
CTIS2024-514844-10-00
Institut Curie
Retinoblastoma
Start: 2010-03-18
Target: 195
Updated: 2025-07-01
Phase 3
Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. LevoHeartShock
Recruiting
CTIS2024-513811-29-00
CHRU De Nancy
Cardiogenic Shock
Start: 2023-07-03
Target: 610
Updated: 2025-07-30